Orthofix stock.

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Orthofix To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983 ...Orthofix currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the broader medical space are Haemonetics HAE , Quanterix QTRX and Intuitive Surgical ISRG , each carrying a Zacks ...Orthofix Medical Stock Up 3.4 %. Shares of NASDAQ:OFIX opened at $11.19 on Tuesday. Orthofix Medical has a 1 year low of $9.57 and a 1 year high of $23.19. The company has a market cap of $411.31 million, a PE ratio of -2.87 and a beta of 1.05. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.58 and a quick ratio of …Orthofix (OFIX) delivered earnings and revenue surprises of -155.56% and 1.64%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?Nov 24, 2023 · OFIX is a medical device company that provides orthopedic and spine solutions to healthcare providers. The stock has a Morningstar rating of 3 stars, a price/earnings ratio of 45.96, and a dividend yield of 0%. See the latest news, financials, valuations, and sustainability of OFIX on Morningstar.

If you suffered losses exceeding $50,000 investing in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or ...Sealed Air, Alaska Air, and SolarEdge will replace Orthofix Medical , Rambus, and Comfort Systems in the S&P SmallCap 600. ... RMBS stock and Comfort Systems fell 5.9% and …Nov 30, 2023 · Orthofix is a leading global spine and orthopedics company with a comprehensive portfolio of biologics, innovative spinal hardware, bone growth therapies, specialized orthopedic solutions and a leading surgical navigation system. Its products are distributed in 68 countries worldwide. The Company is headquartered in Lewisville, Texas, and has ...

There is no cost or obligation to you. New York, New York-- (Newsfile Corp. - November 15, 2023) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX). Faruqi & Faruqi is a leading minority and Woman-owned national …

Two stock analysts spotted some red flags around the Texas-based company's financial statements. As the pair looked into the numbers, they concluded the ...Orthofix currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the broader medical space are Haemonetics HAE , Quanterix QTRX and Intuitive Surgical ISRG , each carrying a Zacks ...Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will explore the best sources for high-quality really free stock ph...Sep 13, 2023 · Orthofix’s stock has lost 36.6% year to date, while the S&P 500 index SPX, +0.18% has gained 16.2%. Advertisement. Advertisement. Partner Center. Advertisement. Advertisement.

All earnings call transcripts on Orthofix Medical Inc. (OFIX) stock. Read or listen to the conference call. Download the investor presentation - earnings call slides.

Orthofix Medical Inc. announced that Massimo Calafiore has been named incoming President. Mr. Calafiore is currently Chief Executive Officer of LimaCorporate S.p.A., and his appointment to Orthofix is expected to be effective in early 2024, following the completion of LimaCorporate?s previously announced acquisition by Enovis …

Orthofix Schedules Third Quarter Earnings Release and Conference Call for November 8, 2023. LEWISVILLE, Texas, October 18, 2023--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and ... New York, New York--(Newsfile Corp. - November 9, 2023) - Pomerantz LLP is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX). Such ...há 8 horas ... Orthofix Medical Inc (OFIX) stock has fallen -43.67% over the last 12 months, and the average rating from Wall Street analysts is a Buy.há 8 horas ... Orthofix Medical Inc (OFIX) stock has fallen -43.67% over the last 12 months, and the average rating from Wall Street analysts is a Buy.Orthofix Medical Inc. (NASDAQ:OFIX) shares fell 5.4% to $10.52 in pre-market trading. Sealed Air will replace Orthofix Medical in the S&P SmallCap 600, …Jun 22, 2023 · Orthofix Medical's merger with SeaSpine has not significantly impacted investor sentiment or market expectations. See why we reiterate hold on OFIX stock. Orthofix’s stock price dropped about 25% following its announcement, down to about $13.56. Orthofix SeaSpine CEO Chutes and Ladders executives C-suite Devices Connect

Sep 10, 2023 · The stock sells at ~1x forward sales and has created marginal value above its net asset value ($1.12 for every $1 invested, to be precise). Investors have priced the company at just 1.12x the ... Orthofix Medical Stock Performance OFIX stock opened at $11.12 on Monday. The company has a quick ratio of 1.13, a current ratio of 2.58 and a debt-to …Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus. The Company operates through two segments: Global Spine and Global Orthopedics. The Global Spine segment consists of three product categories: Bone Growth Therapies, Spinal Implants, and Biologics.LEWISVILLE, Texas, September 12, 2023--Orthofix Medical Inc. (NASDAQ: OFIX), a leading global spine and orthopedics company, today announced that Catherine Burzik, Chair of the Orthofix Board of ...There is no cost or obligation to you. New York, New York-- (Newsfile Corp. - November 17, 2023) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX). Faruqi & Faruqi is a leading minority and Woman-owned national …Institutional investors purchased a net $2.8 million shares of OFIX during the quarter ended June 2019 and now own 96.43% of the total shares outstanding. This ...

Conference Call. Orthofix will host a conference call today at 8:30 AM Eastern time to discuss the Company's financial results for the third quarter of 2022. Interested parties may access the conference call by dialing (888) 330-2508 in the U.S. and Canada, and (240) 789-2735 in all other locations, and referencing the access code 9556380.3 analysts have issued 12-month price targets for Orthofix Medical's shares. Their OFIX share price targets range from $12.00 to $16.00. On average, they predict the company's share price to reach $14.00 in the next twelve months. This suggests a possible upside of 22.0% from the stock's current price.

Third quarter net sales of $114 million, an increase of 1% on a reported basis and 5% on a constant currency basis over prior year Global Orthopedics net sales growth of 19% on a constant currency basis driven by commercial channel investments Biologics net sales growth of 8% driven by new product introductions Bone Growth Therapies net sales growth of 3% driven by the commercial roll-out of ...Had Orthofix not performed such manipulation in Q3, the stock would already be well below $30. So again, just to be clear, Orthofix's past history of Medicare and accounting fraud are not the ...Orthofix Medical. stock was originally listed at a price of $11.75 in Dec 31, 1997. If you had invested in Orthofix Medical stock at $11.75, your return over the last …The ownership structure of Orthofix (OFIX) stock is a mix of institutional, retail and individual investors. Approximately 86.20% of the company’s stock is owned by Institutional Investors, 2.18% is owned by Insiders and 11.62% is owned by Public Companies and Individual Investors. 2.18% Insiders. DEAR SHAREHOLDERS, I am extremely proud of how Orthofix upheld our commitments to surgeons and patients in 2021, while making important investments in our new product pipeline and business operations, all during the continuing challenges of the ongoing global pandemic. We accelerated our strategic plan by investing in our …Conference Call and Webcast. Orthofix and SeaSpine will host a joint conference call and webcast today at 8:00 a.m. ET to discuss the merger. The conference call can be accessed by dialing +1 (833 ...Orthofix’s stock price dropped about 25% following its announcement, down to about $13.56. Orthofix SeaSpine CEO Chutes and Ladders executives C-suite Devices ConnectThe SeaSpine Board and Orthofix Board unanimously recommends that SeaSpine stockholders approve the merger. Orthofix Board formed a strategic steering committee. A special meeting of Orthofix stockholders has been scheduled for January 4, 2023 to vote on a proposal to approve the issuance of Orthofix common stock in the …

Orthofix Medical Inc. Enters into Financing Agreement with Blue Torch Finance LLC. Nov. 08. CI. Earnings Flash (OFIX) ORTHOFIX MEDICAL Reports Q3 Revenue $184M, vs. Street Est of $185.8M. Nov. 08. MT. Orthofix Medical Inc. Revises Earnings Guidance for the Year Ending December 31, 2023.

Good afternoon, and welcome to the Orthofix Third Quarter Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded for... c3b41ec3.BzU3iP6lsIXEN-7Ys8kbgOO0nwRMY8GvRoczYwW_WQQ.MEdz4cjc2OTpVqeU7KZW1NOZ611 …

Orthofix (OFIX) delivered earnings and revenue surprises of -155.56% and 1.64%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?If you purchased or acquired securities in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).What are the best stocks to buy? Learn how you can make that decision for yourself at InvestorPlace. With the help of experienced financial advisors, InvestorPlace can give you the info you need to form an effective investment strategy. So ...Orthofix (OFIX) delivered earnings and revenue surprises of -155.56% and 1.64%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?Mar 7, 2023 · Orthofix Medical Inc. (NASDAQ:NASDAQ:OFIX) Q4 2022 Earnings Conference Call March 6, 2023 4:30 PM ETCompany ParticipantsAlexa Huerta - Senior Director,... Orthofix’s recent financial performance also informs the Hold rating. While the company has shown some growth, with a modest year-over-year increase in sales, it has fallen slightly below market ...Find the latest Orthofix Medical Inc. (OM2.F) stock quote, history, news and other vital information to help you with your stock trading and investing.Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the publication of the five-year results from the U.S. clinical study comparing the M6-C ™ artificial cervical disc with anterior cervical discectomy and fusion (ACDF). Published in TheSpine Journal, patients treated with the M6-C disc ...Orthofix Medical Inc. OFIX shares fell 5.4% to $10.52 in pre-market trading. Sealed Air will replace Orthofix Medical in the S&P SmallCap 600, effective prior to the open of trading on Dec. 18.Orthofix Medical (NASDAQ: OFIX) is owned by 92.92% institutional shareholders, 13.59% Orthofix Medical insiders, and 0.00% retail investors. Cooper Robert Gaines is the largest individual Orthofix Medical shareholder, owning 1.53M shares representing 4.15% of the company. Cooper Robert Gaines's Orthofix Medical shares are currently valued at ...Compare OFIX With Other Stocks. Orthofix Medical Inc. develops, produces and markets medical devices. The Company offers spine fixation, biological and other orthopedic and spine solutions. Orthofix Medical Inc., formerly known as Orthofix International N.V., is headquartered in Lewisville, Texas. ORTHOFIX MEDICAL INC revenue from 2010 to 2023.

OFIX is a medical device company that provides orthopedic and spine solutions to healthcare providers. The stock has a Morningstar rating of 3 stars, a …“Orthofix is a leader in both the demineralized bone matrices (DBM) and cellular allograft markets, and the launch of OsteoCove significantly strengthens our biologics portfolio and builds on our mission to deliver best-in-class products in every major bone grafting category,” said Tyler Lipschultz, President, Orthofix Global Biologics.SeaSpine shares ceased trading on the Nasdaq Global Select Market at 8:00 p.m. Eastern time on January 4, 2023, and holders of SeaSpine common stock are receiving 0.4163 shares of Orthofix common ...Orthofix Medical. stock was originally listed at a price of $11.75 in Dec 31, 1997. If you had invested in Orthofix Medical stock at $11.75, your return over the last …Instagram:https://instagram. imp oilbest online dating apptop consumer staples etfsforex trader demo account Dec 1, 2023 · Orthofix Medical has a beta of 1.02, meaning that its stock price is 2% more volatile than the S&P 500. Comparatively, Surmodics has a beta of 1.15, meaning that its stock price is 15% more volatile than the S&P 500. If you purchased or acquired securities in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). organic food stocksforex and taxes Under the terms of the agreement, which was unanimously approved by the Boards of Directors of both companies, SeaSpine shareholders will receive 0.4163 shares of Orthofix common stock for each ...Orthofix Medical Inc. (NASDAQ: OFIX) and SeaSpine Holdings Corporation today announced the successful completion of their previously announced merger of equals following the approval of each company’s stockholders at respective special meetings of stockholders held today. Of votes cast, 99% of SeaSpine common shares were voted in … best stock analyst ratings 12 de set. de 2023 ... Why Orthofix Medical Inc's (OFIX) Stock Is Down 30.17% ... One of the most dreaded feelings for an investor is when the stock they just bought is ...LEWISVILLE, Texas-- (BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX) today reported its financial results for the quarter ended March 31, 2022. Net sales were $106.4 million, earnings per share (“EPS”) was $ (0.22), and adjusted EPS was $ (0.10). “We're very pleased with our financial and operational performance in the …